InsiderClue
Insiders · Profile

FRATTAROLI JOSEPH

Chief Financial Officer at Inhibikase Therapeutics. Filing since 19 May 2022. CIK 0001272668

Company
Date
Role
Action
Shares
Amount
Of holding
IKT Inhibikase Therapeutics, Inc.
19 May 2022
Chief Financial Officer
Bought
3,948
$2.54K
8.9%
1 decision on file.